Because of the rising incidence and lethality of esophageal adenocarcinoma, Barrett's
esophagus (BE) is an increasingly important premalignant target for cancer prevention. BE …

Background: Endoscopic ablation of Barrett's esophagus, including associated dysplasia
and adenocarcinoma, can be achieved by various techniques, but few long-term results are …

In the last 5 years, endoscopic therapy for high-grade intraepithelial neoplasia (HGIN) and
early cancer (EC) in Barrett oesophagus has emerged as an effective and safe alternative to …

Abstract [Norman Barrett]'s esophagus represents replacement of normal distal esophageal
squamous epithelium with specialized columnar epithelium containing goblet cells. Typically …

The excellent efficacy, side-effect profile, and cost-effectiveness appear to make RFA the
intervention of choice in cases of high-grade dysplasia. RFA for low-grade dysplasia may be …

BACKGROUND: Esophagectomy for early esophageal adenocarcinoma is associated with
increased operative mortality and morbidity, but possibly a decreased recurrence rate …

Endoscopic resection for early esophageal cancer is a very precise endoscopic surgical
technique and having experience in endoscopic resection is mandatory to perform these …

Endoscopic eradication therapy (EET) has become a standard of care for treatment of
dysplastic Barrett's esophagus (BE) and early Barrett's neoplasia. EET mainly consists of …

Abstract Non-dysplastic mucosa (ND-) in Barrett's esophagus (BE) shows clonal molecular
aberrations, loss of cell cycle control, and other features of “neoplasia.” These changes …

In Barrett's esophagus, the stratified squamous epithelium lining the esophagus is replaced
by specialized intestinal-type columnar epithelium. The prevalence of Barrett's esophagus …